Elite Pharmaceuticals, Inc. – Transcripts

OTC: ELTP
Share price (6/4/26): $0.40
Market cap (6/4/26): $431 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Earnings Revised 02/27/26 Elite Pharmaceuticals, Inc., Q3 2026 Earnings Call, Feb 18, 2026 02/18/26

CY 2025

Earnings Revised 11/17/25 Elite Pharmaceuticals, Inc., Q2 2026 Earnings Call, Nov 17, 2025 11/17/25

Earnings Revised 08/15/25 Elite Pharmaceuticals, Inc., Q1 2026 Earnings Call, Aug 15, 2025 08/15/25

Earnings Revised 07/04/25 Elite Pharmaceuticals, Inc., 2025 Earnings Call, Jul 01, 2025 07/01/25

Earnings Revised 02/14/25 Elite Pharmaceuticals, Inc., Q3 2025 Earnings Call, Feb 14, 2025 02/14/25

CY 2024

Earnings Revised 11/15/24 Elite Pharmaceuticals, Inc., Q2 2025 Earnings Call, Nov 15, 2024 11/15/24

Earnings Revised 08/20/24 Elite Pharmaceuticals, Inc., Q1 2025 Earnings Call, Aug 15, 2024 08/15/24

Earnings Revised 08/26/24 Elite Pharmaceuticals, Inc., Q4 2024 Earnings Call, Jul 02, 2024 07/02/24

Earnings Revised 02/15/24 Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 02/15/24

CY 2023

Earnings Revised 11/15/23 Elite Pharmaceuticals, Inc., Q2 2024 Earnings Call, Nov 15, 2023 11/15/23

Earnings Revised 10/31/23 Elite Pharmaceuticals, Inc., Q1 2024 Earnings Call, Aug 15, 2023 08/15/23

Earnings Revised 06/30/23 Elite Pharmaceuticals, Inc., 2023 Earnings Call, Jun 30, 2023 06/30/23

Earnings Revised 02/15/23 Elite Pharmaceuticals, Inc., Q3 2023 Earnings Call, Feb 15, 2023 02/15/23

CY 2022

Earnings Revised 11/15/22 Elite Pharmaceuticals, Inc., Q2 2023 Earnings Call, Nov 15, 2022 11/15/22

Earnings Revised 08/16/22 Elite Pharmaceuticals, Inc., Q1 2023 Earnings Call, Aug 16, 2022 08/16/22

Earnings Revised 06/30/22 Elite Pharmaceuticals, Inc., 2022 Earnings Call, Jun 30, 2022 06/30/22

Earnings Revised 02/15/22 Elite Pharmaceuticals, Inc., Q3 2022 Earnings Call, Feb 15, 2022 02/15/22

CY 2021

Earnings Revised 11/16/21 Elite Pharmaceuticals, Inc., Q2 2022 Earnings Call, Nov 16, 2021 11/16/21

Earnings Revised 08/17/21 Elite Pharmaceuticals, Inc., Q1 2022 Earnings Call, Aug 17, 2021 08/17/21

Earnings Revised 06/15/21 Elite Pharmaceuticals, Inc., 2021 Earnings Call, Jun 15, 2021 06/15/21

Earnings Revised 02/17/21 Elite Pharmaceuticals, Inc., Q3 2021 Earnings Call, Feb 17, 2021 02/17/21

CY 2020

Earnings Revised 11/17/20 Elite Pharmaceuticals, Inc., Q2 2021 Earnings Call, Nov 17, 2020 11/17/20

Earnings Revised 08/17/20 Elite Pharmaceuticals, Inc., Q1 2021 Earnings Call, Aug 17, 2020 08/17/20

Earnings Revised 06/30/20 Elite Pharmaceuticals, Inc., 2020 Earnings Call, Jun 30, 2020 06/30/20

Other Revised 06/23/20 Elite Pharmaceuticals, Inc. - Shareholder/Analyst Call 06/23/20

Earnings Revised 02/11/20 Elite Pharmaceuticals, Inc., Q3 2020 Earnings Call, Feb 11, 2020 02/11/20

CY 2017

Earnings Revised 11/10/17 Elite Pharmaceuticals, Inc., Q2 2018 Earnings Call, Nov 10, 2017 11/10/17

CY 2012

Earnings Revised 02/15/12 Elite Pharmaceuticals Inc., Q3 2012 Earnings Call, Feb 15, 2012 02/15/12

CY 2011

Earnings Revised 11/15/11 Elite Pharmaceuticals Inc., Q2 2012 Earnings Call, Nov 15, 2011 11/15/11

Earnings Revised 08/16/11 Elite Pharmaceuticals Inc., Q1 2012 Earnings Call, Aug 16, 2011 08/16/11

Earnings Revised 06/30/11 Elite Pharmaceuticals Inc., Q4 2011 Earnings Call, Jun 30, 2011 06/30/11

Earnings Revised 02/14/11 Elite Pharmaceuticals Inc., Q3 2011 Earnings Call, Feb 14, 2011 02/14/11

CY 2010

Earnings Revised 08/17/10 Elite Pharmaceuticals Inc., Q1 2011 Earnings Call, Aug-17-2010 08/17/10